{"id":999696,"date":"2026-09-02T07:05:16","date_gmt":"2026-09-02T11:05:16","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/"},"modified":"2026-09-02T07:05:16","modified_gmt":"2026-09-02T11:05:16","slug":"sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/","title":{"rendered":"Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>FOSTER CITY, Calif., Sept.  02, 2026  (GLOBE NEWSWIRE) &#8212; Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management will participate in two upcoming investor conferences.<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt\">Cantor 2026 Global Healthcare Conference in New York, NY on Wednesday, September 9, 2026, with a fireside chat at 1.35pm ET (link <a href=\"https:\/\/protect.checkpoint.com\/v2\/r01\/___https:\/sqps.onstreamsecure.com\/origin\/enliven\/players\/EnlivenPlayer.html?customerId=22&amp;eventId=85710161&amp;checkCompany=1&amp;checkEmail=1&amp;checkName=1___.YzJ1OnNhZ2ltZXRiaW9zY2llbmNlczpjOm86ZDg3MGQ2NDJiOWNiY2ZlY2MzZmFiYzgzZmQxMGNmNDc6Nzo1MDg4OmE2ZWNhMGQ3ODgzNmNhNGYyYWQwNzQxMmFjZGQ5ZWE5YWExNmI3MmE2YTRlY2JkYjAzOTg2NjQ1ODJhZWY2Nzc6aDpUOkY\" rel=\"nofollow\" target=\"_blank\">here<\/a>).<\/li>\n<li style=\"margin-bottom:8pt\">H.C. Wainwright 28<sup>th<\/sup> Annual Global Investment Conference in New York, NY on Monday, September 14, 2026.\n<\/li>\n<\/ul>\n<p>The\u00a0fireside chat will be available in the Investors &amp; Media section of Sagimet\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=D7A5wFGflB2S255iUXzlurkNoHW5lDtmy9j-KazZxv8ZLxuqQu3Iv7h1FbXNHmDPkmvM7LzKANimqMqq7joCW66i7broE67F1-EMN-LTu8c=\" rel=\"nofollow\" target=\"_blank\">www.sagimet.com<\/a>, with an archived replay available for 90 days following the live event.<\/p>\n<p>\n        <strong>About\u00a0Sagimet Biosciences<\/strong>\n      <\/p>\n<p>Sagimet is a clinical-stage biopharmaceutical company developing novel FASN inhibitors designed to target dysfunctional metabolic and fibrotic pathways in conditions resulting from the overproduction of the fatty acid, palmitate. FASN is a regulator of lipid synthesis, a key pathway implicated in multiple diseases, such as acne, MASH\u202fand certain FASN-dependent tumor types. For additional information about Sagimet, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=D7A5wFGflB2S255iUXzlur-ebasPK0uwYvw9jKppBs-4Nvlmhibaixz_XRgPrYoDYzanYaVi6ye6DxqH_M9eS3NgIhV2sPcdBvNxUrygffk=\" rel=\"nofollow\" target=\"_blank\">www.sagimet.com<\/a>.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Joyce Allaire\u00a0<br \/>LifeSci Advisors\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kdLeccXv8g6rf5aX0DQ1ARe1JKEOD8vtLyhWtMkqvgRpCD2qUjQiDZOYeN4LZiU38VpQhvNG8Zl-4tkPfpVlNH96IV0OaNHMal0AEt4D9c_GYrfx1ilsUV_uTXonLLbtBIPD3Q4kKgNYvRous9oeZCYjkCl-mOqOccNgeAxe1dQQJo2XAwBp3DsJYCnuQ6saiTujhmvU5Sk01obcdOUXlyOTNiy3VMew7NQtPU4lSlu9D7JXPhhG06Asne2glNvkMa6o70JtLd3qEm9zoFBoTrbU7C4PiThSdPFTC7ZMzi9RIjQtL1D5CKTelhDHX3tQv0dRyv-YSHNOJKqEqAHb_lC6OEvW4yZpMu4tmudNKW5g6MAorQWxytEB-o6fWq5d9KaDSBaFbr5xECu3SW-NLjIpMxp-HZ9OmttL6Ti3UmzwlfIo--IKOnW-zearvgcQLmMApMm7Rxk37j1WPLOAMX2TLB07fZI3RugeVgLV2XQSgZEr6gm8s6ovOX3uGLFgGCtYtUUmMKdmT4reHrZl-4VHfXHcUa7NGKb1Ek6JVR1GMN2dOp8XsFHwilOPgxq2lju3n2SoyOscHcZbBP2DutsfEQ8M3ZYnDRggH7B8VOcRztmc1TN7ISWc9E4b8a7QPA6jLAcYFV3RpNTZtX0i7lyjv-OlJeNF7I-9FyenXAg0cZUG7RRQnb3uVM-YVTHWQO5UCIjM0J0_M0NEu7OCnIPOCjEMElGj3TihRM8sqlxHKxAnih0DqqoWHQLqGnZvNqYu3IHvBa-H8xWg-Q03HqVnyiJ-KuKrga54vTjaoOOtOqRAF_sdIorM2Hes1A7CUFT5F7nPBgy0mCr7UiA1v-j5bCXDxBYuvhsz3ENOzQ-y8yVwptf0DLtWpzfPSXDCahEnFvwjbH0A5-AWSI-nJR9xbDnPUkUgp1knPNsnTiKa-rDvU0KzeSLdW9xjwqJf\" rel=\"nofollow\" target=\"_blank\">JAllaire@LifeSciAdvisors.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Maggie Whitney<br \/>LifeSci Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gCBg7-EtQvz4Yig2QOftP-h1lUDbZdtV4WSwf5qFYkQV7ByH9PZSeZFCFCuPywqf3NM-vsL2acHpiTT54RDwUJyIYdDfDhgyt174uNALmQVsaxComWaHY-B2ZFmm7jTbrXya6Qt5g_WXkQj0IA8uDY7R_ixK-dftyIStpWszzrndVa6y9U0oJlGLn22UgwndTQCvH4gTvmT6sAxa_zzOVw4Z7tyBSx9YZb5VnpIfi9O_psywsWqXtX--rm4OobLaX7RVvz0XYQUxg0OatwcxL2SmjPGkDX6hQfYhsmiYtkA=\" rel=\"nofollow\" target=\"_blank\">mwhitney@lifescicomms.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTc1MCM3ODEzNjY4IzIyMDg2NDg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OTEwMTc2NzQtMzAxZS00MGI4LWEwYWUtOWYwMTkwY2I0OGJhLTEyMjAyMDEtMjAyNi0wOS0wMi1lbg==\/tiny\/Sagimet-Biosciences-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>FOSTER CITY, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) &#8212; Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management will participate in two upcoming investor conferences. Cantor 2026 Global Healthcare Conference in New York, NY on Wednesday, September 9, 2026, with a fireside chat at 1.35pm ET (link here). H.C. Wainwright 28th Annual Global Investment Conference in New York, NY on Monday, September 14, 2026. The\u00a0fireside chat will be available in the Investors &amp; Media section of Sagimet\u2019s website at\u00a0www.sagimet.com, with an archived replay available for 90 days following the live event. About\u00a0Sagimet Biosciences Sagimet is a clinical-stage biopharmaceutical company developing novel FASN inhibitors designed to target dysfunctional &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-999696","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"FOSTER CITY, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) &#8212; Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management will participate in two upcoming investor conferences. Cantor 2026 Global Healthcare Conference in New York, NY on Wednesday, September 9, 2026, with a fireside chat at 1.35pm ET (link here). H.C. Wainwright 28th Annual Global Investment Conference in New York, NY on Monday, September 14, 2026. The\u00a0fireside chat will be available in the Investors &amp; Media section of Sagimet\u2019s website at\u00a0www.sagimet.com, with an archived replay available for 90 days following the live event. About\u00a0Sagimet Biosciences Sagimet is a clinical-stage biopharmaceutical company developing novel FASN inhibitors designed to target dysfunctional &hellip; Continue reading &quot;Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-02T11:05:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTc1MCM3ODEzNjY4IzIyMDg2NDg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences\",\"datePublished\":\"2026-09-02T11:05:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\\\/\"},\"wordCount\":193,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxOTc1MCM3ODEzNjY4IzIyMDg2NDg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\\\/\",\"name\":\"Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxOTc1MCM3ODEzNjY4IzIyMDg2NDg=\",\"datePublished\":\"2026-09-02T11:05:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxOTc1MCM3ODEzNjY4IzIyMDg2NDg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxOTc1MCM3ODEzNjY4IzIyMDg2NDg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences - Market Newsdesk","og_description":"FOSTER CITY, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) &#8212; Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management will participate in two upcoming investor conferences. Cantor 2026 Global Healthcare Conference in New York, NY on Wednesday, September 9, 2026, with a fireside chat at 1.35pm ET (link here). H.C. Wainwright 28th Annual Global Investment Conference in New York, NY on Monday, September 14, 2026. The\u00a0fireside chat will be available in the Investors &amp; Media section of Sagimet\u2019s website at\u00a0www.sagimet.com, with an archived replay available for 90 days following the live event. About\u00a0Sagimet Biosciences Sagimet is a clinical-stage biopharmaceutical company developing novel FASN inhibitors designed to target dysfunctional &hellip; Continue reading \"Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-02T11:05:16+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTc1MCM3ODEzNjY4IzIyMDg2NDg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences","datePublished":"2026-09-02T11:05:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/"},"wordCount":193,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTc1MCM3ODEzNjY4IzIyMDg2NDg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/","name":"Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTc1MCM3ODEzNjY4IzIyMDg2NDg=","datePublished":"2026-09-02T11:05:16+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTc1MCM3ODEzNjY4IzIyMDg2NDg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTc1MCM3ODEzNjY4IzIyMDg2NDg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/999696","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=999696"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/999696\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=999696"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=999696"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=999696"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}